Yes, companies need to do more on climate change. But, here's what they need first, according to leaders from the International Chamber of Commerce.» Read More
CNBC's Meg Tirrell reports the family members of the man being treated for the Ebola virus have been ordered to stay home until October 19th.
Discussing Ebola fear and the dangers of the virus spreading, with Dr. Leigh Vinocur, American College of Emergency Physicians.
CNBC's Meg Tirrell reports the person with the first confirmed case of Ebola in the U.S. is in serious but stable condition, and all of his contacts are being monitored.
A breast cancer drug from Roche known as Perjeta helped patients live nearly 16 months longer compared with Herceptin and chemotherapy alone. CNBC's Meg Tirrell provides insight to the data.
Three teenagers from Ireland took home the top prize in Google's Science Fair competition, reports CNBC's Kaya Tausche.
India's low-cost mission to Mars successfully entered the orbit, crowning India as the first country to complete the trip at its maiden attempt.
The FDA authorized Tekmira's ebola drug for potential use through an expanded access program. CNBC's Meg Tirrell reports which other companies are working on drugs to fight ebola.
CNBC's Meg Tirell reports the latest projections on the Ebola virus.
The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.
World carbon dioxide emissions will hit a record high this year, driven by China's growth and keeping the world far off track from the deep cuts needed to limit climate change, a study said on Sunday.
Derek Herrera, wounded U.S. Marine Captain, discusses how ReWalk's wearable robotic exoskeleton device has impacted his life for the better and demonstrates the device.
ReWalk CEO Larry Jasinski discusses just how big the market for wearable robotic exoskeleton devices could get.
Unlike a hurricane, tornado or snowstorm, the ends and beginning of droughts are very hard to predict.
CNBC's Meg Tirrell runs down today's top health care headlines, including a major move by President Obama to fight the Ebola virus and the latest on Enterovirus D68.
Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.
"Big Bang" actress Mayim Bialik is a self-proclaimed science geek (she has a Ph.D.) and wants to get kids excited about math and science.
CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.
CNBC's Meg Tirrell reports an American missionary doctor serving in Liberia has tested positive for Ebola.
Two major tech investors have plowed $1.5 million into Helion Energy to help it develop a technology that hasn’t worked, according to Oilprice.com.